Previous studies reported that anti-IL-1 and anti-IL-12 mAbs significantly suppressed arthritis, whereas anti-TNF-α therapy had little effect in this model [2-5], and blockade of IL-6 had no effect in established CIA [6], indicating different therapeutic mechanisms in RA [7,8]. The gene discussed is TNF; the disease is arthritic joint disease.